Activated Mouse Notch1 Transactivates Epstein-Barr Virus Nuclear Antigen 2-Regulated Viral Promoters
暂无分享,去创建一个
L. Strobl | U. Zimber-Strobl | G. Bornkamm | G. Laux | H. Höfelmayr | Charlotte Stein | G. Marschall
[1] S. Minoguchi,et al. Functional Replacement of the Intracellular Region of the Notch1 Receptor by Epstein-Barr Virus Nuclear Antigen 2 , 1998, Journal of Virology.
[2] Raphael Kopan,et al. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.
[3] G. Struhl,et al. Nuclear Access and Action of Notch In Vivo , 1998, Cell.
[4] A. Bigas,et al. Notch1 and Notch2 Inhibit Myeloid Differentiation in Response to Different Cytokines , 1998, Molecular and Cellular Biology.
[5] E. Fuentes-Pananá,et al. Characterization of the CBF2 Binding Site within the Epstein-Barr Virus Latency C Promoter and Its Role in Modulating EBNA2-Mediated Transactivation , 1998, Journal of Virology.
[6] B. Trask,et al. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. , 1998, Immunity.
[7] L. Strobl,et al. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa. , 1997, Immunobiology.
[8] S. Minoguchi,et al. RBP-L, a transcription factor related to RBP-Jkappa , 1997, Molecular and cellular biology.
[9] B. Fowlkes,et al. Notch activity influences the alphabeta versus gammadelta T cell lineage decision. , 1997, Cell.
[10] B. Fowlkes,et al. Notch Activity Influences the αβ versus γδ T Cell Lineage Decision , 1997, Cell.
[11] I. Bernstein,et al. Inhibition of granulocytic differentiation by mNotch1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Rohn,et al. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma , 1996, Journal of virology.
[13] G. Weinmaster,et al. An Activated Form of Notch Influences the Choice between CD4 and CD8 T Cell Lineages , 1996, Cell.
[14] L. Girard,et al. Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. , 1996, Genes & development.
[15] S E Lux,et al. Constitutively active human Notch1 binds to the transcription factor CBF1 and stimulates transcription through a promoter containing a CBF1-responsive element. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[17] J. Hsieh,et al. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 , 1996, Molecular and cellular biology.
[18] H. Weintraub,et al. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Pawlita,et al. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines. , 1996, The Journal of general virology.
[20] S. Minoguchi,et al. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jκ/Su(H) , 1995, Current Biology.
[21] K. Gupta,et al. A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase. , 1995, Genome research.
[22] F. Schweisguth,et al. The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signaling. , 1995, Genes & development.
[23] J. Posakony,et al. Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. , 1995, Genes & development.
[24] Christel Brou,et al. Signalling downstream of activated mammalian Notch , 1995, Nature.
[25] David Ish-Horowicz,et al. Primary neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila neurogenic gene Delta , 1995, Nature.
[26] J. Hsieh,et al. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. , 1995, Science.
[27] E. Kremmer,et al. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). , 1995, Virology.
[28] D. Thorley-Lawson,et al. A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.
[29] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1 , 1995, Journal of virology.
[30] E. Kremmer,et al. B‐cell proliferation and induction of early G1‐regulating proteins by Epstein‐Barr virus mutants conditional for EBNA2. , 1995, The EMBO journal.
[31] Kenji Matsuno,et al. Notch signaling. , 1995, Science.
[32] L. Waltzer,et al. RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. , 1995, Nucleic acids research.
[33] L. Waltzer,et al. The human J kappa recombination signal sequence binding protein (RBP‐J kappa) targets the Epstein‐Barr virus EBNA2 protein to its DNA responsive elements. , 1994, The EMBO journal.
[34] F. Moreau-Gachelin,et al. The Spi‐1/PU.1 and Spi‐B ets family transcription factors and the recombination signal binding protein RBP‐J kappa interact with an Epstein‐Barr virus nuclear antigen 2 responsive cis‐element. , 1994, The EMBO journal.
[35] L. Strobl,et al. Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element , 1994, Journal of virology.
[36] U. Zimber-Strobl,et al. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes , 1994, Journal of virology.
[37] M. Fortini,et al. The suppressor of hairless protein participates in notch receptor signaling , 1994, Cell.
[38] T. Honjo,et al. Epstein‐Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP‐J kappa, the homologue of Drosophila Suppressor of Hairless. , 1994, The EMBO journal.
[39] Raphael Kopan,et al. An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. , 1994, Development.
[40] H. Weintraub,et al. The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. , 1994, Development.
[41] E. Kieff,et al. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Ling,et al. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. , 1994, Science.
[43] T. Honjo,et al. The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor , 1994, Molecular and cellular biology.
[44] I. Bernstein,et al. A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. , 1994, Blood.
[45] G. Klein,et al. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. , 1993, Virology.
[46] D. Housman,et al. Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis , 1993, Molecular and cellular biology.
[47] E. Kremmer,et al. The Epstein‐Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis‐element of the terminal protein 1 gene promoter. , 1993, The EMBO journal.
[48] D. Gutsch,et al. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter , 1992, Journal of virology.
[49] E. Kieff,et al. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression , 1991, Journal of virology.
[50] A. Polack,et al. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift. , 1991, Oncogene.
[51] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[52] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element , 1991, Journal of virology.
[53] E. Kieff,et al. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.
[54] D. Gutsch,et al. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus , 1991, Journal of virology.
[55] G. Lenoir,et al. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene , 1991, Journal of virology.
[56] R. Fåhraeus,et al. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[57] E. Kieff,et al. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1 , 1990, Journal of virology.
[58] J. Knutson. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization , 1990, Journal of virology.
[59] M. Rowe,et al. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein , 1990, Journal of virology.
[60] J. Banchereau,et al. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23 , 1990, Journal of virology.
[61] J. Strominger,et al. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[62] T. Honjo,et al. A protein binding to the Jk recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif , 1989, Nature.
[63] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Honjo,et al. Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin Jx segment , 1989 .
[65] W. Hammerschmidt,et al. Genetic analysis of immortalizing functions of EpsteinBarr virus in human B lymphocytes , 1989, Nature.
[66] T. Honjo,et al. Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin J kappa segment. , 1989, Nucleic acids research.
[67] J. Banchereau,et al. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[68] E. Kieff,et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[69] P. L. Deininger,et al. DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.
[70] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[71] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[72] L. Heston,et al. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye , 1982, Journal of virology.
[73] W. Gilbert,et al. Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.
[74] R. Pulvertaft. A study of malignant tumours in Nigeria by short-term tissue culture , 1965, Journal of clinical pathology.
[75] H. Kikutani,et al. Epstein-Barr Virus Nuclear Protein 2 Transactivates a cis-Acting CD 23 DNA Element , 2022 .